Cleared Traditional

K223622 - FaceHeart Vitals Software Development Kit (FH vitals SDK) (FDA 510(k) Clearance)

Sep 2023
Decision
270d
Days
Class 2
Risk

K223622 is an FDA 510(k) clearance for the FaceHeart Vitals Software Development Kit (FH vitals SDK). This device is classified as a Software For Optical Camera-based Measurement Of Pulse Rate, Heart Rate, Breathing Rate, And/or Respiratory Rate (Class II - Special Controls, product code QME).

Submitted by Faceheart Corp. (Grand Cayman, KY). The FDA issued a Cleared decision on September 1, 2023, 270 days after receiving the submission on December 5, 2022.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2785. The Device Uses Software Algorithms To Analyze Video Signal And Estimate Pulse Rate, Heart Rate, Respiratory Rate And/or Breathing Rates. This Device Is Not Intended To Independently Direct Therapy..

Submission Details

510(k) Number K223622 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 2022
Decision Date September 01, 2023
Days to Decision 270 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code QME - Software For Optical Camera-based Measurement Of Pulse Rate, Heart Rate, Breathing Rate, And/or Respiratory Rate
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2785
Definition The Device Uses Software Algorithms To Analyze Video Signal And Estimate Pulse Rate, Heart Rate, Respiratory Rate And/or Breathing Rates. This Device Is Not Intended To Independently Direct Therapy.